| Literature DB >> 35335170 |
Fatima Hameedat1, Sahar Hawamdeh2, Soraya Alnabulsi1, Aref Zayed1.
Abstract
Steroids are compounds widely available in nature and synthesized for therapeutic and medical purposes. Although several analytical techniques are available for the quantification of steroids, their analysis is challenging due to their low levels and complex matrices of the samples. The efficiency and quick separation of the HPLC combined with the sensitivity, selectivity, simplicity, and cost-efficiency of fluorescence, make HPLC coupled to fluorescence detection (HPLC-FLD) an ideal tool for routine measurement and detection of steroids. In this review, we covered HPLC-FLD methods reported in the literature for the steroids quantification in clinical, pharmaceutical, and environmental applications, focusing on the various approaches of fluorescent derivatization. The aspects related to analytical methodology including sample preparation, derivatization reagents, and chromatographic conditions will be discussed.Entities:
Keywords: HPLC; derivatization; fluorescence; quantification; steroids
Mesh:
Substances:
Year: 2022 PMID: 35335170 PMCID: PMC8949805 DOI: 10.3390/molecules27061807
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Representation of fluorescent derivatizing agents used in steroid analysis by HPLC-FLD.
Figure 2Derivatization using fluorophore-containing reagents for steroids analysis by HPLC-FLD.
Derivatization reagents and conditions used in steroid quantification by HPLC-FLD.
| Reagent | Target Steroid | Sample Preparation and Derivatization Conditions | Reference |
|---|---|---|---|
| Estrogens | Sample was extracted by SPE C18. | Mao et al. 2004 [ | |
| 1-Anthroyl nitrile (1-AN) | 18-Oxygenated corticosteroids, 18-hydroxycortisol, 18-hydroxycortisone and 18-oxocortisol, Pregnenolone and C21 steroids; especially corticoids | Sample was extracted by SPE or LLE with a mixture of diethyl ether and dichloromethane. | Kurosawa et al. 1995 [ |
| 9-Anthroyl nitrile (9-AN) | Glucocorticoids; | Sample was extracted by LLE or SPE. | Glowka et al. 2009 [ |
| 2-(11H-Benzo[a]carbazole-11-yl) ethyl carbonochloridate (BCEC-Cl) | E1, E2, E3, BPA, NP, OP | Sample was extracted by DLLME. | Wu et al. 2015 [ |
| 9-Phenanthrene | Brassinosteroids | Sample was extracted by LLE. | Gamoh |
| 10-Ethyl-acridone- | Estrogens and | Sample was extracted by LLE or SPE. | Zhang et al. 2012 [ |
| Sulfuric acid |
F and | Sample was extracted by SPE or LLE. | Nozaki et al. 1991 [ |
| 7-Methoxycoumarin-3-carbonyl azide (MC-CON3) | 7α-hydroxycholesterol | Sample was extracted by LLE and purified by normal-phase SPE. | Saisho et al. 1998 [ |
| 2-(4-Carboxyphenyl)-5,6-dimethylbenzimidazole(CDB) | Corticosteroids, BPA and alkylphenols | Sample was extracted by LLE. | Katayama et al. 1991 [ |
| Benzamidine | 17-hydroxycorticosteroids | Sample was extracted by LLE. | Seki et al. 1984 [ |
| 4-(4,5-Diphenyl-1 | BPA | Sample was extracted by LLE or SPE. | Sun et al. 2004 [ |
| 4-(4,5-Diphenyl-1 | EE | Sample was extracted by the SPE disc method (C18 SPE disk). | Ali et al. 2020 [ |
| 1,2-Diamino-4,5-methylenedioxybenzene (DMB) | α-Dicarbonyl compounds; prednisolone, PN and 21-hydroxycorticosteroids | Sample was extracted by LLE. | Yamaguchi et al. 1991 [ |
| 2-(4-Carboxyphenyl)-5,6-dimethylbenzimidazole (BODIPY FL hydrazide) | Aldehydes and ketones; progesterone, | Sample was extracted by LLE. | Katayama et al. 1998 [ |
| Dansyl hydrazine | F, Butane acid-(5-androsten-17-one-3beta-ol)-diester (A1998)[ | Sample was extracted by LLE. | Kawasaki et al. 1979 [ |
| Naproxen acyl chloride in toluene | Cholesterol and sitosterol | Sample was extracted by LLE. | Lin et al. 2007 [ |
| Dansylaminophenylboronic acid | Brassinolide and castasterone | Sample was extracted by LLE. | Motegi et al. 1994 [ |
| 9-Fluorenylmethyl chloroformate (Fmoc-Cl) | E1, E2, E3, BPA, NP, OP | Samples were extracted by MSPE. | Qianyu Li et al. 2018 [ |
| 2-(11H-Benzo[a]carbazole-11-yl)- | FFA | The samples were extracted by supercritical CO2 and organic solvent extraction. The extracted samples were derivatized in BCETS in a solution of K2CO3 at 84 °C; then the mixture was cooled down to RT and diluted with DMF. | Li et al. 2011 [ |
| Benzimidazo[2, 1-b]quinazoline-12(6H)-one-5-ethylimidazole ester (BQEIC) | OP, NP, TBP, BPA, E1, E2, E3 | The samples were extracted by LLE. | Liu et al. 2018 [ |
Abbreviation: solid-phase extraction (SPE), liquid–liquid extraction (LLE), 4-octylphenol (OP), 4-tert-octylphenol (4-t-OP), 4-nonylphenol (NP), 4-tert-butylphenol (TBP), bisphenol A (BPA), estrone (E1), 17β-estradiol (17β-E2), 17α-estradiol (17α-E2), estriol (E3), free fatty acids(FFA), 17α-ethinylestradiol (EE2), ethinylestradiol (EED), cortisol (F), cortisone (E), 4,40-(1,2-diethylethylene)diphenol (HEX), prednisolone (PL), prednisone (PN), 6β-hydroxycortisol (6β-OHF), 6β-hydroxyprednisolone (6β-OHP) and 6β-hydroxycortisone (6β-OHE), room temperature (RT).
Figure 3Fluorescence emission of steroids after treatment with sulfuric acid.
Figure 4Esterification of primary alcohol functionality of cortisol and cortisone by 2-(4-carboxyphenyl)-5,6-dimethylbenzimidazole (CDB) in the presence of 4-piperidinopyridine and 1-isopropyl-3-(3-dimethylaminopropyl) carbodiimide (IDC) perchlorate. Prednisolone secondary alcohol shows no reaction.
Figure 5Esterification of primary alcohol functionality of cortisol and cortisone by 9-anthroyl nitrile (9-AN) or 1-anthroyl nitrile (1-AN).
Figure 6Fluorescent derivatization of 18-oxygenated corticosteroids by or 1-anthroyl nitrile (1-AN).
Figure 7Fluorescent derivatization of carbonyl functionality of cortisol by dansyl hydrazine.
Figure 8Fluorescent derivatization of ketolic-containing corticosteroids by benzamidine.
Figure 9Fluorescent derivatization of ketol-containing corticosteroids to quinoxaline derivative.
Figure 10Derivatization of cholesterol by naproxen acyl chloride.
Figure 11Derivatization of 7α-hydroxycholesterol (7-HC) by 1-anthroyl nitrile (1-AN) or 7-methoxycoumarin-3-carbonyl azide (MC-CON3).
Figure 12Derivatization of progesterone by 4,4-difluoro-5,7-dimethyl-4-bora-3a,4adiaza-s-indacene-3-propionohydrazide (BOD-IPYTM FL hydrazide).
Figure 13Derivatization of pregnenolone by 1-anthroyl nitrile (1-AN).
Figure 14Derivatization of 17β-estradiol by p-nitrobenzoyl chloride.
Figure 15Derivatization of alkyl phenols by 2-(4-carboxyphenyl)-5,6-dimethylbenzimidazole (CDB) or 4-(4,5-diphenyl-1H-imidazol-2-yl) benzoyl chloride (DIB-Cl).
HPLC-FLD method conditions used for steroid detection.
| Detected Steroids | Sample Type | Column Chemistry | Mobile Phase ( | Derivatization Agent | Excitation (λex) and Emission Wavelengths (λem) (nm) | Extraction Method | LOD | References |
|---|---|---|---|---|---|---|---|---|
| PL | Human plasma | C18 | MeOH:ACN:1.0 M ammonium acetate (38:25:45) | DMB | 350, 390 | LLE | 3 ng/mL | Yamaguchi et al. 1991 [ |
| F and E | Biological samples | Keystone Hypersil | H2O:MeOH:ACN (50:33.3:16.7) | 9-AN | 305–395, 430–470 | SPE | F: 50 pg | Haegele et al. 1991 [ |
| F | Human serum | C18 | 1: 10 mM potassium biphthalate | Sulfuric acid-ethanol | 365, 520 | - | 0.30 pg/dL | Nozaki et al. 1991 [ |
| F | Human urine | C18 | Gradient of ACN: | Sulfuric acid-ethanol | 365, 520 | SPE | 0.26 pg/dL | Nozaki et al. 1992 [ |
| 7α-Hydroxycholesterol | Dog plasma | Develosil Ph-5 | Acetonitrile: | 1-AN | 338, 411 | LLE | 4 pg | Saisho et al. 1998 [ |
| Corticosteroids | Urine | Silica | 2-Propanol–hexane | 9-AN | 370, 470 | Enzyme hydrolysis, extraction with 0.5 M NaOH | NR | Neufeld et al. 1998 [ |
| F and E | Human plasma | C18 | ACN: 0.3 mM | 9-AN | 360, 460 | SPE | 3.0 ng/mL | Glowka et al. 2009 [ |
| Corticosterone | Rat urine | CN | ACN: H2O (24.5:75.5) | post-column reaction with | 460, 510 | LLE | 0.5 pmol | Sudo et al. 1990 [ |
| F | Human hair | C18 | MeOH:H2O | sulfuric acid | 360, 480 | LLE | 1 pg/mg | Gao et al. 2010 [ |
| EE2, E2, and BPA | Human urine and aqueous samples | C18 | ACN:MeOH:H2O (30:15:55) | - | 280, 310 | FPSE | E2: 20 pg/mL | Kumar et al. 2014 [ |
| BPA, NP, E2, EE2, and E3 | Human urine | C18 | Gradient elution of ACN and H2O | E2, E3: 282, 315 | SPE | BPA and E2: 2.7 μg/L | Mao et al. 2004 [ | |
| E, testosterone, methyltestosterone, bolasterone, testosterone acetate, progesterone | Urine | C18 | 0.01 M Tb(NO3)3, 0.1 M sodium dodecyl sulfate (SDS), and 20% | - | 245, 547 | SPE | Down to 100 pg/mL | Amin et al. 1993 [ |
| BPA and 8 | Rat plasma and blood | C18 | MeOH:Water (10:90) | 2-(4-carboxyphenyl)-5,6- | Derivatized: 336, 440 | LLE | BPA: 0.1 pg/mL | Katayama et al. 2001 [ |
| progesterone and 17-hydroxyprogesterone | Serum from pregnant and non-pregnant women | Wakosil 5C4 | Acetonitrile:Water (7:3) | BODIPY FL hydrazide | 495, 516 | LLE | 550–3700 fmol per 10 μL | Katayama et al. 1998 [ |
| aldosterone, corticosterone, F, E, dexamethasone, fluocinolone | Human plasma | C18 | Water:MeOH (25:75) containing 5 mmol/L tetramethylammonium hydrogen sulphate | CDB | 334, 418 | LLE | 0.06–0.3 pg per 100 μL | Katayama et al. 1992 [ |
| BPA | Breast Milk | C18 | 1: ACN:H2O:MeOH (72:13:15) | DIB-Cl | 350, 475 | SPE then LLE | 0.11 ng/mL | Sun et al. 2004 [ |
| BPA | Human blood serum and ascitic fluid samples | C18 | 1: ACN: | DIB-Cl | 350, 475 | LLE | 0.04 ppb | Kuroda et al. 2003 [ |
| BPA | Rat brain | C18 | 1: ACN: | DIB-Cl | 350, 475 | LLE | 0.3 ppb in 60 μL rat brain | Sun et al. 2002 [ |
| F, E, PL, PN, | Human plasma and urine | Cosmosil 5SL | diethylene dioxide: ethyl acetate:chloroform: | 9-AN | 360, 460 | LLE | F, E, PL and PN: 0.1 ng/mL | Shibata et al. 1997 [ |
| Corticosterone | Rat serum | C18 | 60% MeOH: 40% 5 mM | - | 375, 485 | LLE | 0.1 ng | Mason et al. 1992 [ |
| 18-Oxygenated corticosteroids, 18-hydroxycortisol, 18- | Human urine | μBondasphere phenyl | A: 10 mM ammonium acetate: MeOH (50:50) | 1-AN | 370, 470 | LLE and SPE | 0.1 pmol | Kurosawa et al. 1995 [ |
| Cholesterol and sitosterol | Saliva and urine biosamples, Cow milk, and Soybean milk | C8 | MeOH:isopropanol:H2O | naproxen acyl chloride | 231, 352 | LLE | 25 nM per 10 μL injected volume | Lin et al. 2007 [ |
| Pregnenolone | Rat brain | C18 | MeOH:H2O (9:1) | 1-AN | 370, 470 | SPE | NR | Shimada et al. 1996 [ |
| C21 steroids; corticoids | Steroid standards | C18 | MeOH:H2O:cyclodextrin | 1-AN | 360, 460 | NR | NR | Shimada et al. 1991 [ |
| Triamcinolone | Human plasma | C18 | ACN and 0.3 mM | 9-AN | 360, 460 | SPE | 1 ng/mL | Glowka et al. 2006 [ |
| Butane acid-(5-androsten-17-one-3beta-ol)-diester (A1998) | Rat plasma | C18 | 25 mM acetate buffer (pH 3.7):ACN | Dansyl hydrazine | 332, 516 | LLE | 10 ng/mL | Visser et al. 2000 [ |
| Alfaxalone and pregnanolone | Rat plasma | C18 | Gradient mixture of | Dansyl Hydrazine | 350, 520 | - | 0.025 μg/mL | Peng et al. 2007 [ |
| EED | Oral contraceptive tablets | STAR RP-18e | ACN:H2O (47:53) | - | EED: 285, 310 | - | EED: 0.0538 μg/ml | Sarafinovska et al. 2006 [ |
| EED and drospirenone | Oral contraceptive tablets | STAR RP-18e RP | ACN:H2O (47:53) | - | 285, 310 | - | EED: 0.00065 μg/mL | Sarafinovska et al. 2009 [ |
| EED | Coated tablets | LiChroCART 100RP | ACN:H2O (50:50) | - | 280, 310 | - | EED: 0.02 μg/mL | Silva et al. 2013 [ |
| Sodium E1 |
Raw materials and | 5 ODS2 | TEA phosphate | Postcolumn on line photochemical derivatization | 280, 410 or 312 | - | 0.01–1.38 pmol | Gatti et al. 1998 [ |
| E1, 17β-Estradiol, | Fish, chicken, aquaculture pond water sample | C18 | Gradient program of | BCEC-Cl | 279, 380 | DLLME | 0.02–0.07 µg/L | Wu et al. 2015 [ |
| E1, | Cow and river Buffalo | C18 | 1: ACN:H2O:Formic Acid (40:60:0.4) | - | 280, 310 | LLE and SPE | 5–10 ng/kg | Shahbazi et al. 2016 [ |
| α- and β-Trenbolone | Bovine muscle and liver | C18 | MeOH:H2O (60:40) | - | 364, 460 | LLE then SPE | bovine muscle: 0.2 ng/g | Yoshioka et al. 2000 [ |
| NP, 4-nonylphenol | Fish and shellfish | Inertsil PH | Gradient program of A: H2O | - | 275, 300 | LLE | NP NP1EO and NP2EO | Tsuda et al. 2000 [ |
| Nonylphenol and its ethoxylates | Fish tissue | Hypersil APS | Hexane:ethanol (98:2) | - | 230, 300 | Pressurized fluid extraction | 4–15 ng/mL | Datta et al. 2002 [ |
| E2 and EE2 | Poultry litter | C18 | Gradient program of A: H2O | - | 280, 312 | LLE | E2: 4.0 μg/kg | Lu et al. 2014 [ |
| E2 and EE2 | Waste Water | C18 | Gradient program of A: H2O | - | 282, 306 | SPE | 2.5 ng/L | Liz et al. 2017 [ |
| E3, E2, EE2, | Water, sediment | Poroshell 120 EC | H2O:ACN 50:50 | - | 275, 310 | SPE | Water: 6–24 ng/L | Perez et al. 2015 [ |
| E2, 17α-EE2, and E1 | Water | C18 | Gradient program of A: ACN | - | 230, 302 | SPE | 10 to 1100 | Patrolecco et al. 2013 [ |
| OP, | Wastewater | C18 | Gradient program of A: 5% | EASC | 262, 430 | SPE | 0.3–0.7 ng/L | Zhang et al. 2012 [ |
| E2 and | Tap, surface and waste water | C18 | Water:acetonitrile mixture (50:50) | - | 280, 310 | DLLME | E2: 2.0 ng/L | Lima et al. 2013 [ |
| BPA, 17β-estradiol, and 17α-ethynyl estradiol | Drinking water | LiChro-sorbs RP18 | 10 mM H3PO4:55% MeOH (45:55) | - | 280, 310 | PAC | BPA: 201 ng/L | Yoon et al. 2003 [ |
| 17α- and 17β-Trenbolone | River water | C18 | Gradient program of | - | 359, 458 | SPE | 4 ng/L | Durhan et al. 2005 [ |
| NP, | municipal wastewater treatment plants | C18 | Gradient program of | - | 229, 310 | LLE | OP: 2 ng/L | Snyder et al. 1999 [ |
| E2, E3, BPA, | environmental | C18 | ACN:0.02 mol/L phosphate solution (45:55) | - | 227, 315 | Synthesized in-tube SPME device | 0.006–0.10 ng/mL | Wen et al. 2006 [ |
| E2, E3, EE2, | River water | C18 | Gradient program of | - | 230, 290 | on-line SPE | 20–50 ng/L | Ying et al. 2002 [ |
| Endocrine disruptors; BPA and EE2 | Environmental water samples | C18 | MeOH:0.025 mol/L Na2HPO4 buffer (70:30) | - | 220, 315 | A poly(acrylamide-vinylpyridine) | BPA: 0.064 ng/mL | Fan et al. 2005 [ |
| Brassinosteroids | Plant: | C18 | ACN: H2O (90:10) | 9-Phenanthreneboronic acid | 305, 375 | LLE | 50 pg | Gamoh et al. 1989 [ |
| Brassinolide | Arabidopsis thaliana, Daucus | C18 | Gradient program of | - | 305, 375 | UA-DLLME | 8.0 ng/L | Lv et al. 2014 [ |
| Brassinolide and castasterone | Pollen of orange (Citrus sinensis Osbeck) | C18 | ACN:H2O (80:20) | Dansylaminophenylboronic | 345, 515 | LLE | NR | Motegi et al. 1994 [ |
| Norgestrel, norethindrone, EE2, gestodene, and norethisterone acetate | Meat samples | Hypersil GOLD | Gradient program of | Fmoc-Cl | 250, 395 | MSPE | 1.4 × 103–8.7 × 103 | Qianyu Li et al. 2018 [ |
| F and E | Human urine samples | C18 | ACN:0.3 mM orthophosphoric acid (470: 530) | 9-AN | 360, 460 | LLE | LLOQ: F: 27.6 nmol/L | Kosicka et al. 2018 [ |
| FFA | Edible oils and foodstuff | C8 | Gradient system: | BCETS | 279, 380 | Supercritical CO2 and organic solvent extraction | 0.22–1.06 ng/mL | Li et al. 2011 [ |
| OP, NP, TBP, BPA, E1, E2, E3 | Milk samples | C18 | Gradient program of | BQEIC | 302, 401 | LLE | 10.5–13.8 ng/L | Liu et al. 2018 [ |
| E3, 2-OHE2, 17β-E2, 17α-E2, EE2, HEX | Dairy products | C18 | Gradient Flow | - | 280, 310/320 | HF-LPME | 0.23–14.8 μg/kg | Bárbara Socas-Rodríguez et al. 2014 [ |
| Zearalenone | Edible oil | C18 | Gradient program of | 274, 456 | SPE | 10 μg/kg | Drzymala et al. 2015 [ | |
| EE2, E1, E2, E3, and progesterone | Drinking water and wastewater samples | C18 | Gradient program of | 200, 315 | SPE | Drinking water: 1–3.8 ng/L | Kozłowska-Tylingo et al. 2015 [ | |
| E3, E2, E1 | Human urine | C18 | Gradient program of | 280, 310 | VA-DLLME-FOA | E3: 0.01 ng/mL | Wang et al. 2015 [ | |
| 17-α-E2, 17-β-E2 benzoate | Environmental water samples | Zorbax Eclipse SB-C18 | Gradient program of | 265, 311 | IF-IHLME | 17-α-Estradiol: 0.04 ng/mL | Zhang et al. 2017 [ | |
| E2 and EE2 | Tap water samples | Pursuit 5 C18 column | ACN:H2O (50:50), with 200 μL of H3PO4 | 230, 306 | Nanoparticles of graphene oxide/γ-Fe2O3 as a | E2: 2.7 ng/L | Fernanda Nunes Ferreira et al. 2020 [ | |
| 17-E2 and E3 | Water samples | C18 | H2O:MeOH:ACN | 280, 310 | ultrasonication assisted DLLME | DLLME-HPLC/FLD: 7.16–69.22 ng/L | Zhang et al. 2020 [ | |
| E2, 1,3,5(10)-Estratriene-3,17β-diol | Fish and prawn tissue samples | ODS C18 | H2O:MeOH (30:70) | 280,310 | MISPE | 0.023 mg/L | Jiang et al. 2009 [ | |
| BPA, EE2, 4-t- | River water | C18 | Gradient program of | 277, 307 | Disposable pipette extraction (DPX) | BPA, EE2, 4-OP and 4-NP: 0.30 μg/L | Gabriela Corazza et al. 2017 [ | |
| E1 and EE2 | Digested sludge | C18-PFP | A: H2O | 280, 310 | ultrasonic liquid extraction | E1: 0.305 μg/g | Vitória L. Louros et al. 2019 [ | |
| E2 | Milk sample | XDB-C18 | MeOH:H2O | 280, 310 | SPE | 0.7 ng/mL | Yanan Yuan et al. 2019 [ | |
| Nine BPs | milk samples | C18 | Gradient program of | 230, 305 | ultrasonically with acetonitrile and cleaned | 1.0–3.1 µg/kg | Xiong et al. 2017 [ | |
| EE | river water samples | 5C18 MS-II | ACN: 5.0 mM Tris-HNO3 buffer, pH 7.4 (60:40) | 310, 400 | C18 SPE disk | 7.4 ng/L | Ali et al. 2020 [ | |
| E3, 17β-estradiol glucuronide, | wastewater | UPLC C18 | Gradient program of | 280, 310 | Molecularly Imprinted SPE | 1.4 to 2.5 ng/mL | Rayco Guedes-Alonso et al. 2015 [ |
Abbreviation: solid phase extraction (SPE), liquid–liquid extraction (LLE), dispersive-liquid–liquid extraction (DLLME), ultrasonic-assisted dispersive liquid–liquid microextraction (UA-DLLME), vortex-assisted dispersive liquid–liquid microextraction method based on floating organic acid droplet (VA-DLLME-FOA), ionic liquid foam floatation coupled with an ionic liquid-based homogeneous liquid–liquid microextraction (IF-IHLME), magnetic solid phase extraction (MSPE), fabric phase sorptive extraction (FPSE), molecularly imprinted solid-phase extraction (MISPE), hollow fiber liquid-phase microextraction (HF-LPME), 4-octylphenol (OP), 4-tert-octylphenol (4-t-OP), 4-nonylphenol (NP), 4-tert-butylphenol (TBP), bisphenol A (BPA), estrone (E1), 17β-estradiol (17β-E2), 17α-estradiol (17α-E2), estriol (E3), free fatty acids (FFA), 17α-ethinylestradiol (EE2), ethinylestradiol (EED), cortisol (F), cortisone (E), 4,40-(1,2-diethylethylene)diphenol (HEX), prednisolone (PL), prednisone (PN), 6β-hydroxycortisol (6β-OHF), 6β-hydroxyprednisolone (6β-OHP) and 6β-hydroxycortisone (6β-OHE), room temperature (RT).
Figure 16Derivatization of alfaxalone by dansyl hydrazine.